Pavel Klener
- Oncology top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 2%
- Genetics top 5%
- Immunology top 10%
- Co-authors
- Magdalena KlánováMarek TrněnýLadislav AnděraPavel OtáhalPetra VočkováRobert PytlíkJ ŽivnýDana Průková
- Topics
- Lymphoma Diagnosis and Treatment (54 papers)Chronic Lymphocytic Leukemia Research (37 papers)Viral-associated cancers and disorders (18 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Pavel Klener
114 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 104
- Oncology 638
- Molecular Biology 631
- Pathology and Forensic Medicine 508
- Genetics 338
- Immunology 266
Countries citing papers authored by Pavel Klener
This map shows the geographic impact of Pavel Klener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Klener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Klener more than expected).
Fields of papers citing papers by Pavel Klener
This network shows the impact of papers produced by Pavel Klener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Klener. The network helps show where Pavel Klener may publish in the future.
Co-authorship network of co-authors of Pavel Klener
This figure shows the co-authorship network connecting the top 25 collaborators of Pavel Klener. A scholar is included among the top collaborators of Pavel Klener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavel Klener. Pavel Klener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 8 | |
| 8 | 38 | |
| 9 | 18 | |
| 10 | 25 | |
| 11 | 8 | |
| 12 | 4 | |
| 13 | 63 | |
| 14 | 27 | |
| 15 | 21 | |
| 16 | 31 | |
| 17 | 6 | |
| 18 | 72 | |
| 19 | 8 | |
| 20 | [ABL1, SRC and other non-receptor protein tyrosine kinases as new targets for specific anticancer therapy]. | 3 |
About Pavel Klener
Pavel Klener is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology, having authored 121 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (54 papers), Chronic Lymphocytic Leukemia Research (37 papers) and Viral-associated cancers and disorders (18 papers). The work is most often cited by research in Genetics (338 citations), Pathology and Forensic Medicine (508 citations) and Oncology (638 citations). Pavel Klener has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Magdalena Klánová, Marek Trněný, Ladislav Anděra, Pavel Otáhal, Petra Vočková, Robert Pytlík, J Živný, Dana Průková, Tomáš Etrych and Jan Molinský. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.